4//SEC Filing
Harper Molly 4
Accession 0001161697-25-000446
CIK 0001369568other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 5:00 PM ET
Size
7.5 KB
Accession
0001161697-25-000446
Insider Transaction Report
Form 4
Harper Molly
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.001 per share
2025-12-08+1,413→ 9,106 total - Exercise/Conversion
Restricted Stock Units
2025-12-08−1,413→ 148,497 total→ Common Stock (1,413 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Derivative securities vested in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026.
- [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001871470
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 5:00 PM ET
- Size
- 7.5 KB